Navigation Links
Ranbaxy gets US FDA approval for Lisinopril

Ranbaxy Pharmaceuticals Inc (RPI) has received a tentative approval from the US FDA for Lisinopril tablets. Lisinopril is recommended for hypertension, either alone for initial therapy or with other classes of anti-hypertenive agents. It is also used as adjunctive therapy in the management of heart failure and patients who do not respond to diuretics. //

However it expects to launch the product only in June 2002, when the original patent expires on the drug, Zestril. Zestril is a registered trademark of Astra Zeneca UK Ltd. A wholly-owned subsidiary of Ranbaxy Laboratories Ltd, RPI expects to be able to access retail pharmacy outlets, wholesalers, hospitals and generic distributors in the US, only post - June 2002.

Sales in 2000 for Lisinopril touched $ 1.2 billion. It is sold under two brands in the US market , of which Zestril alone sold $ 0.66 billion in 2000. The tentative approval has been given for a single entity form of Lisinopril. An Abbreviated New Drug Application (ANDA) submission by Ranbaxy, for Lisinopril and Hydrochlorithizide is still outstanding and pending approval from the US FDA.

The tentative US FDA approval has been given for Lisinopril tablets USP 2.5 mg, 5 mg, 10 mg 20 mg and 40 mg. Based on kinetic studies, it has been deemed to be a bio-equivalent and therapeutically equivalent to Zestril tablets. The tentatively approved formulation is the result of R&D efforts that focussed on the Active Pharmaceutical Ingredient and the bio-equivalent formulation, both of which were developed in-house.


'"/>




Page: 1

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Ranbaxy Labs Entry Into Anti-Acne Market
3. Ranbaxy trying to make inroads in herbal drugs market
4. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
5. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
6. Ranbaxy opens Drug discovery centre in Gurgaon
7. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
8. SRL Ranbaxy offers quicker bird flu diagnostic test
9. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
10. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
11. Ranbaxy Expands By Acquiring A Generic Company In Belgium

Post Your Comments:
(Date:11/9/2009)...ith new cells regained sexual function, study says... -- Researchers were able to restore sexual functi...penile tissue in the lab and implanting it, a new ...a ways off, researchers say the technique could on... in men. , "We were able to show the tissue was...
(Date:11/9/2009)...na, Nov. 9 /PRNewswire-FirstCall/ - Hard To Treat ...d today that Novartis, a US$41 billion internation...n HTDS, H1N1 Vaccine partner, Zhejiang Tianyuan Bi...vartis of Switzerland will begin a five-year, $1 b... will dramatically increase its investment in its ...
(Date:11/9/2009)... Tomorrow may be too late when it comes to p...ding to TOPS Club, Inc. (Take Off Pounds Sensibly)... , (Vocus) November 9, 200...venting or improving a diabetes condition, accordi...the nonprofit weight-loss support organization., ,...
(Date:11/9/2009)... New study highlights positive influence of ... Rosemont, IL (Vocus) November 9, 2009...th decreases. Recent research has highlighted the ...help prevent these issues. However, a new study pu...Health: A Multidisciplinary Approach reveals that...
(Date:11/9/2009)... Calif., Nov. 9 Actress Mariska Ha... philosophy on Saturday to raise awareness abou...throughout California by building healing and well...ts were created to give one to each of the estimat...Angeles County,s domestic violence shelters. ,,...
Breaking Medicine News(10 mins):Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3
... six months old is not advisable as it may lead to...uld rather breastfeed them exclusively, scientists...oided for the first six months, and certain items ...ACAAI), reported online edition of health magazine...
...scarriage, for a couple, appears to rise along wit... mother// according to a recent report by research...They conducted their study on nearly 14,000 women ...icipants who delivered a baby. The researchers fou...
...ia have suggested that cross-immunity created in r...in protect against infection // by related seroty...engue epidemics. This finding would help understa...he dominant serotype," said lead author Helen Wear...
... disease caused by filarial worm Onchocerca volvul...s craw craw is an endemic disease in Bioko Island,... black flies causes weakening in affected individu...he environmental conditions and altitude of Bioko ...
...iversity of Florida, Gainesville, mice based exper...enes to treat hereditary diseases of the heart.// ... in mice affected with muscular dystrophy that dam...soon as early next year for patients with Pompe di...
... of north India, encephalitis has once again struc...e virus has already claimed the lives of 36 childr...ies claim the currently spreading virus was not th... any of the 223 cases that have been reported sinc...
Other Medicine News:Health News:Risk of Miscarriage Rises with Father’s Ag 2Health News:Waxing And Waning Of Dengue Epidemics Attributed To Cross-Immunity 2Health News:Waxing And Waning Of Dengue Epidemics Attributed To Cross-Immunity 3Health News:River Blindness Incidence Reduced With Effective Treatment 2Health News:Gene Therapy Technique for Inherited Heart Problems in The Pipeline 2Health News:Gene Therapy Technique for Inherited Heart Problems in The Pipeline 3Health News:Gene Therapy Technique for Inherited Heart Problems in The Pipeline 4Health News:36 Children Die of Encephalitis in Uttar Pradesh 2
(Date:11/7/2009)...ACH, Fla., Nov. 7 Most patients wi...toms that signal an oncoming HAE attack giving the...d decrease the morbidity associated with that atta...t the 2009 American College of Allergy, Asthma &am...ition of symptoms such as fatigue and nausea, whic...
(Date:11/6/2009)...N.C., Nov. 6 Oxygen Biot... announced that a previously approved reverse spli...t of trading on Monday, Nov. 9, 2009 on a 1-for-15.... shares will trade under the new symbol OXBT. The...0 9, when the split becomes effective. ,, "This...
(Date:11/6/2009)..., FORT WASHINGTON, Pa., Nov. 6 In ...ation (FDA), McNeil Consumer Healthcare, Division ...all of a limited number of product lots of TYLENOL...th the distinctive red EZ-OPEN CAP. McNeil is init...istic smell or taste associated with these lots th...
Breaking Medicine Technology:Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Craneware Announces Fiscal Year End Results 56424 1Craneware Announces Fiscal Year End Results 56424 2Craneware Announces Fiscal Year End Results 56424 3Invision Sally Jobe Names Breast Network Medical Director 56421 1Invision Sally Jobe Names Breast Network Medical Director 56421 2Cancer Drug May Fight Alzheimers 56418 1
...for Sept. 29, LA JOLLA, Calif., June 30 TorreyPi...nced that data presented at the 50th Annual,Scient...ed that, in,addition to meeting the primary endpoi...ny,s lead AMPA/kainate-type glutamate receptor ant...portant secondary endpoints in a,306-patient Phase...
...s Corporation (Nasdaq: UTHR ) and its wholly-owne...bmission of a New Drug Application,(NDA) to the U....g approval,of an inhaled formulation of treprostin...hypertension (PAH), a chronic, life-threatening di...g which the FDA will examine the,application for c...
Other Medicine Technology:Data Presented at American Headache Society's Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics' Tezampanel 2Data Presented at American Headache Society's Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics' Tezampanel 3New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration 2New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration 3New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration 4
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: